Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Advanced Medicine, Analytical Science, Bioprocessing - Upstream & Downstream, Technology and Equipment

Fiber-based chromatography to improve productivity in downstream AAV processing

sponsored by Cytiva

Available On-Demand

December 2, 2020 at 17:00 UK

Speaker: Dr. Peter Guterstam
Product Manager, Next Generation Resins and Technologies, Cytiva

As more AAV-based gene therapies move towards the clinic, there is a growing need for scalable and cost-effective production processes that maintain virus quality. In downstream processing, the capture chromatography step is a bottleneck. To address the need for higher productivity, we are developing a novel fiber technology, Fibro, which uses a proprietary structure that overcomes the diffusional and flow limitations of packed- bed chromatography. The fiber structure is highly open to facilitate mass transfer without diffusion, as with membrane and monolith technologies. Unlike those options, the Fibro structure provides a large surface area resulting from an additive manufacturing process.

Available On-Demand

Subscribe to The Medicine Maker Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine